Human-Relevant, Translational Platforms
Translational human cell–based NeuroMuscle™ and NeuroHTS™ systems generate human-relevant, translationally informative data—bridging discovery and patient outcomes.

At Ananda Devices, we develop human-relevant organ-on-a-chip systems that replicate neuromuscular and neuronal physiology, enabling predictive preclinical data generation aligned with New Approach Methods (NAMs) and the FDA Modernization Act.
Browse Our Case StudiesTrusted by
Numerous Pharma, Biotech & Governmental Institutions
Worldwide
At Ananda Devices, we're redefining preclinical testing to reflect real human biology. With more than 99% of neurological drugs failing in clinical trials, the industry needs a better way.
Translational human cell–based NeuroMuscle™ and NeuroHTS™ systems generate human-relevant, translationally informative data—bridging discovery and patient outcomes.
Collaborating with leading pharmaceutical organizations and the U.S. FDA to advance regulatory-aligned, human-relevant testing strategies.
Ready-to-run, scalable human biology platforms that reduce reliance on animal models while supporting global 3Rs initiatives.
Continuously monitor neuronal and neuromuscular networks—capturing structure, function, connectivity, and treatment response over time, including countermeasure development of drug or toxin effects.
NeuroHTS™ provides precisely organized networks for improved neuronal connectively, morphology and function - all in one assay. Advantages include precisely organized neuronal networks for reproducible screening, multiparametric high-throughput workflows, compatibility with primary & iPSC-derived neurons, and ideal applicability for neurotoxicity, regeneration & CNS drug discovery.


We collaborate with pharmaceutical, biotechnology, Government and academic innovators to accelerate translational research and generate predictive human data that strengthens early development decisions.
We provide the tools for partners advance studies with greater reproducibility, scalability, and translational relevance.
Explore More Collaborations
Patient-derived neuromuscular models supporting Myasthenia Gravis drug-development decisions.

Supporting qualification of our platform as a NAM drug development tool and toxin testing.
Founded in 2015, Ananda Devices builds human-relevant organ-on-a-chip platforms that enable predictive, scalable, and ethical preclinical testing beyond animal models.
Explore More Collaborations
Jun 25, 2025 • By Allan Ren
The challenge in neuroscience is the lack of access to human neural tissue, and the historical reliance on animal models. Biological standardization with human data is critically needed.
Read MoreLearn how Ananda's solutions support decisions across drug discovery, toxicology, and translational research.
Have a general inquiry? Email us directly at contact@anandadevices.com